Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Lipella Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Lipella Pharmaceuticals Inc market cap is $924.00.
What is the 52-week high for Lipella Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lipella Pharmaceuticals Inc 52 week high is $0.6407 as of August 16, 2026.
What is the 52-week low for Lipella Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lipella Pharmaceuticals Inc 52 week low is $0.0002 as of August 16, 2026.
What is Lipella Pharmaceuticals Inc stock price today?
Lipella Pharmaceuticals Inc stock price today is $0.0002.
What was Lipella Pharmaceuticals Inc stock price yesterday?
Lipella Pharmaceuticals Inc stock price yesterday was $0.0002.
What is the Price-to-Book ratio of Lipella Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Lipella Pharmaceuticals Inc P/B ratio is 0.0006.
What is the 50-day moving average of Lipella Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Lipella Pharmaceuticals Inc 50-day moving average is $0.0562.